BioCentury
ARTICLE | Company News

Gilead, Teva infectious news

February 25, 2013 8:00 AM UTC

Gilead and Teva settled a March 2010 patent suit claiming Teva's ANDA for a generic version of HIV and HBV drug Viread tenofovir disoproxil fumarate infringes Gilead's U.S. Patent Nos. 5,922,695; 5,9...